Stock NVLG NOVOLOG (PHARM-UP 1966) LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Novolog (Pharm-Up 1966) Ltd

Equities

NVLG

IL0011401515

Ground Freight & Logistics

Market Closed - TEL AVIV STOCK EXCHANGE
Other stock markets
 07:24:09 2024-04-25 am EDT 		5-day change 1st Jan Change
159.4 ILa -1.18% Intraday chart for Novolog (Pharm-Up 1966) Ltd -1.60% +12.17%
Mar. 26 Novolog (Pharm-Up 1966) Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Novolog (Pharm-Up 1966) Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 391.3 782.8 1,423 1,504 1,409 725.7
Enterprise Value (EV) 1 284 755.7 1,401 1,432 1,449 708
P/E ratio 18 x 65 x 36.1 x 36.2 x 29.8 x -17.2 x
Yield 2.11% 2.54% 0.84% 3.16% 2.37% 2.07%
Capitalization / Revenue 0.43 x 0.78 x 1.26 x 1.2 x 0.93 x 0.44 x
EV / Revenue 0.31 x 0.75 x 1.24 x 1.14 x 0.96 x 0.43 x
EV / EBITDA 5.89 x 13.2 x 18.5 x 16.3 x 15.3 x 5.68 x
EV / FCF -13.3 x 11 x 54.4 x 49.6 x 35.7 x 4.51 x
FCF Yield -7.49% 9.13% 1.84% 2.02% 2.8% 22.2%
Price to Book 3.85 x 2.97 x 4.83 x 3.54 x 3.23 x 1.96 x
Nbr of stocks (in thousands) 350,000 463,486 463,586 506,492 508,703 510,718
Reference price 2 1.118 1.689 3.070 2.969 2.770 1.421
Announcement Date 3/12/19 3/19/20 3/17/21 3/14/22 3/20/23 3/26/24
1ILS in Million2ILS
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 911.2 1,004 1,134 1,255 1,508 1,643
EBITDA 1 48.24 57.2 75.62 87.75 94.89 124.5
EBIT 1 31.42 39.78 57.54 70.91 78.44 53.97
Operating Margin 3.45% 3.96% 5.08% 5.65% 5.2% 3.28%
Earnings before Tax (EBT) 1 30.5 18.36 52.52 60.13 68.52 -28.91
Net income 1 21.86 10.14 40.07 42.32 47.8 -42
Net margin 2.4% 1.01% 3.53% 3.37% 3.17% -2.56%
EPS 2 0.0620 0.0260 0.0850 0.0820 0.0930 -0.0824
Free Cash Flow 1 -21.27 68.96 25.78 28.88 40.62 157
FCF margin -2.33% 6.87% 2.27% 2.3% 2.69% 9.55%
FCF Conversion (EBITDA) - 120.56% 34.09% 32.91% 42.81% 126.03%
FCF Conversion (Net income) - 680.3% 64.33% 68.24% 84.98% -
Dividend per Share 2 0.0236 0.0429 0.0259 0.0938 0.0657 0.0294
Announcement Date 3/12/19 3/19/20 3/17/21 3/14/22 3/20/23 3/26/24
1ILS in Million2ILS
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - 40 -
Net Cash position 1 107 27.1 22.2 71.9 - 17.8
Leverage (Debt/EBITDA) - - - - 0.4212 x -
Free Cash Flow 1 -21.3 69 25.8 28.9 40.6 157
ROE (net income / shareholders' equity) 23.3% 5.48% 14.5% 12.4% 11.5% -9.15%
ROA (Net income/ Total Assets) 1.11% 1.28% 1.66% 1.98% 2.08% 1.29%
Assets 1 1,970 792.8 2,416 2,137 2,303 -3,254
Book Value Per Share 2 0.2900 0.5700 0.6400 0.8400 0.8600 0.7300
Cash Flow per Share 2 0.3100 0.4000 0.3800 0.4700 0.3400 0.4600
Capex 1 29.3 25 25.6 30.6 69.5 71
Capex / Sales 3.21% 2.49% 2.26% 2.44% 4.61% 4.32%
Announcement Date 3/12/19 3/19/20 3/17/21 3/14/22 3/20/23 3/26/24
1ILS in Million2ILS
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Ground Freight & Logistics

1st Jan change Capi.
NOVOLOG (PHARM-UP 1966) LTD Stock Novolog (Pharm-Up 1966) Ltd
+12.17% 213M
CANADIAN PACIFIC KANSAS CITY LIMITED Stock Canadian Pacific Kansas City Limited
+6.48% 76.06B
KANSAS CITY SOUTHERN Stock Kansas City Southern
-.--% 26.71B
XPO, INC. Stock XPO, Inc.
+26.61% 12.9B
U-HAUL HOLDING COMPANY Stock U-Haul Holding Company
-9.58% 12.39B
C.H. ROBINSON WORLDWIDE, INC. Stock C.H. Robinson Worldwide, Inc.
-18.72% 8.22B
KNIGHT-SWIFT TRANSPORTATION HOLDINGS INC. Stock Knight-Swift Transportation Holdings Inc.
-18.66% 7.55B
RUMO S.A. Stock Rumo S.A.
-9.19% 7.52B
ALD Stock ALD
-3.88% 5.4B
RYDER SYSTEM, INC. Stock Ryder System, Inc.
+5.99% 5.34B
Other Ground Freight & Logistics
  1. Stock Market
  2. Equities
  3. NVLG Stock
  4. Financials Novolog (Pharm-Up 1966) Ltd